Clinical Study

The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization

Figure 4

OCTA images with associated B-cans of a female patient. ((a)–(c)) CNVs form before treatment, 1 day after treatment, and 1 month after treatment on OCTA. The selected CNV areas were 0.089 mm2, 0.097 mm2, and 0.116 mm2. The flow areas were 0.048 mm2, 0.045 mm2, and 0.060 mm2. ((d)–(f)) B-scans of 3 detections. The CRT was 367 μm, 354 μm, and 287 μm. The subretinal fluids were decreased continuously.
(a)
(b)
(c)
(d)
(e)
(f)